News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151,344 Results
Type
Article (10268)
Company Profile (48)
Press Release (141028)
Section
Business (38459)
Career Advice (249)
Deals (6224)
Drug Delivery (28)
Drug Development (17826)
Employer Resources (33)
FDA (3611)
Job Trends (3309)
News (66178)
Policy (6487)
Tag
Academia (860)
Alliances (13807)
Alzheimer's disease (535)
Approvals (3608)
Artificial intelligence (187)
Bankruptcy (41)
Best Places to Work (2907)
Breast cancer (109)
Cancer (598)
Cardiovascular disease (37)
Career advice (217)
CAR-T (38)
Cell therapy (116)
Clinical research (13990)
Collaboration (336)
Compensation (37)
COVID-19 (824)
C-suite (39)
Cystic fibrosis (56)
Data (539)
Diabetes (69)
Diagnostics (2170)
Drug discovery (45)
Earnings (11950)
Events (19114)
Executive appointments (140)
FDA (3912)
Funding (234)
Gene therapy (81)
GLP-1 (177)
Government (1317)
Healthcare (5415)
Infectious disease (857)
Inflammatory bowel disease (53)
Interviews (44)
IPO (3077)
Job creations (558)
Job search strategy (179)
Layoffs (82)
Legal (913)
Lung cancer (81)
Manufacturing (81)
Medical device (3448)
Medtech (3451)
Mergers & acquisitions (3257)
Metabolic disorders (164)
Neuroscience (657)
NextGen: Class of 2025 (1510)
Non-profit (1640)
Northern California (621)
Obesity (88)
Opinion (79)
Parkinson's disease (47)
Patents (41)
People (10195)
Phase I (4607)
Phase II (6409)
Phase III (4537)
Pipeline (222)
Postmarket research (465)
Preclinical (1895)
Radiopharmaceuticals (103)
Rare diseases (128)
Real estate (1075)
Regulatory (4724)
Research institute (849)
Series A (41)
Southern California (375)
Startups (916)
United States (5007)
Vaccines (158)
Weight loss (50)
Date
Today (54)
Last 7 days (316)
Last 30 days (773)
Last 365 days (11804)
2025 (495)
2024 (11833)
2023 (12171)
2022 (17133)
2021 (17336)
2020 (15635)
2019 (11708)
2018 (8225)
2017 (6882)
2016 (6610)
2015 (7196)
2014 (4891)
2013 (3978)
2012 (4048)
2011 (4041)
2010 (3284)
Location
Africa (274)
Arizona (45)
Asia (11389)
Australia (1890)
California (1221)
Canada (487)
China (154)
Colorado (59)
Connecticut (78)
Europe (26859)
Florida (188)
Illinois (111)
Indiana (67)
Japan (52)
Maryland (201)
Massachusetts (1075)
Michigan (37)
Minnesota (88)
New Jersey (279)
New York (390)
North Carolina (198)
Northern California (621)
Ohio (39)
Pennsylvania (284)
South America (271)
Southern California (375)
Texas (245)
Washington State (207)
151,344 Results for "cortechs ai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software, Expanding Capabilities in Neuroimaging
Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product, NeuroQuant® v5.0, which is currently FDA 510(k) pending.
April 24, 2024
·
2 min read
Press Releases
Cortechs.ai Receives a New NIH Grant for ARIA Detection in Alzheimer’s Disease
July 31, 2024
·
2 min read
Press Releases
Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H
September 3, 2024
·
3 min read
Artificial intelligence
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
January 7, 2025
·
2 min read
·
Tristan Manalac
Business
Investing in AI: Benefits, Regulatory Challenges
In this episode of Denatured, BioSpace’s Head of Insights Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunities, regulatory challenges and uncertainty surrounding AI.
November 7, 2024
·
1 min read
·
Lori Ellis
Drug Development
How AI Could Ease Tension in Clinical Trials
In the third episode of our mini series on artificial intelligence, Lori and guests continue their exploratory discussion on AI and the opportunity in patient lives.
October 10, 2024
·
1 min read
·
Lori Ellis
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Drug Development
AI Return on Investment: Just Because We Can, Should We?
In this episode, Lori and guests continue their exploratory discussion on AI and focus on the challenges of globalization and return on investment.
September 26, 2024
·
1 min read
·
Lori Ellis
Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation
January 10, 2025
·
2 min read
Venture capital
ARCH Fuels Up With $3B to Support Next Class of AI Biotechs
ARCH Venture Partners is the latest venture capital firm to raise a multi-billion-dollar fund. The cash will be used to support new startups working with AI.
September 26, 2024
·
1 min read
·
Annalee Armstrong
1 of 15,135
Next
